Diagnosis and Management of Metastatic ColoRectal Cancer (mCRC): State-of-the-Art Oncology Nursing Practice- More than 140,000 adults in the US will be diagnosed with CRC this year. At the time of diagnosis, a quarter of these patients will have metastases, and 50% to 60% of the remainder will develop metastasis during the course of treatment.
A number of drugs have demonstrated activity in mCRC. However, adherence to guideline-recommended treatment for mCRC is suboptimal, and many patients receive treatment outside of evidence-based, best-practice standards. Because adherence to guidelines has been found to improve outcomes in mCRC, it is imperative that all healthcare professionals improve their ability to adhere to evidence-based practices for the management of this condition.
Oncology nursing professionals play a critical role in the management of cancers, including mCRC. Given the major role of oncology nurses and nurse practitioners as well as the challenges they face while involved in CRC management, it is critical that these individuals are knowledgeable and competent in all aspects of therapy and management. This will allow them to improve their abilities and role within the healthcare team managing these patients.
Distinguish guideline-recommended treatment options for mCRC and the evidence that supports each therapy.
Summarize recent changes to current mCRC guidelines, including the addition of new therapeutic options and opportunities for more targeted therapy in select patient populations.
Recognize toxicities associated with chemotherapy and targeted therapies for treatment of mCRC and develop individual plans to manage these complications
Identify and distinguish resources and guidelines designed to manage treatment-related toxicities in mCRC therapy.1.25 Free CEUs for Nurses
Expires 7/24/15
